Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical experimentation with aerosol antibiotics: current and future methods of administration.
Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Drug Des Devel Ther. 2013 Oct 2;7:1115-34. doi: 10.2147/DDDT.S51303. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24115836 Free PMC article. Review.
Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, Karamanos N, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Int J Nanomedicine. 2012;7:1551-72. doi: 10.2147/IJN.S29997. Epub 2012 Mar 22. Int J Nanomedicine. 2012. PMID: 22619512 Free PMC article. Review.
New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.
Zarogoulidis P, Kioumis I, Ritzoulis C, Petridis D, Darwiche K, Porpodis K, Spyratos D, Parrish S, Browning R, Li Q, Turner JF, Freitag L, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Int J Pharm. 2013 Oct 15;455(1-2):182-8. doi: 10.1016/j.ijpharm.2013.07.040. Epub 2013 Jul 23. Int J Pharm. 2013. PMID: 23891745
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J. Hohenforst-Schmidt W, et al. Among authors: zarogoulidis p, zarogoulidis k. Drug Des Devel Ther. 2013 Jul 18;7:571-83. doi: 10.2147/DDDT.S46393. Print 2013. Drug Des Devel Ther. 2013. PMID: 23898222 Free PMC article.
Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.
Zarogoulidis K, Ziogas E, Boutsikou E, Zarogoulidis P, Darwiche K, Kontakiotis T, Tsakiridis K, Porpodis K, Latsios D, Chatzizisi O, Karapantzos I, Li Q, Kyriazis G. Zarogoulidis K, et al. Among authors: zarogoulidis p. Drug Des Devel Ther. 2013 Jul 23;7:611-7. doi: 10.2147/DDDT.S43184. Print 2013. Drug Des Devel Ther. 2013. PMID: 23901264 Free PMC article. Clinical Trial.
Defense mechanisms of the respiratory system and aerosol production systems.
Zarogoulidis P, Darwiche K, Yarmus L, Spyratos D, Secen N, Hohenforst-Schmidt W, Katsikogiannis N, Huang H, Gschwendtner A, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Med Chem. 2014 Mar;10(2):123-36. doi: 10.2174/157340641130900041. Med Chem. 2014. PMID: 24007475
Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.
Zarogoulidis P, Petridis D, Ritzoulis C, Darwiche K, Kioumis I, Porpodis K, Spyratos D, Hohenforst-Schmidt W, Yarmus L, Huang H, Li Q, Freitag L, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Int J Pharm. 2013 Nov 18;456(2):325-31. doi: 10.1016/j.ijpharm.2013.09.004. Epub 2013 Sep 11. Int J Pharm. 2013. PMID: 24035789
Experimentation with inhaled bronchodilators and corticosteroids.
Zarogoulidis P, Porpodis K, Kioumis I, Petridis D, Lampaki S, Spyratos D, Papaiwannou A, Organtzis J, Kontakiotis T, Manika K, Darwiche K, Freitag L, Tsiouda T, Papakosta D, Zarogoulidis K. Zarogoulidis P, et al. Among authors: zarogoulidis k. Int J Pharm. 2014 Jan 30;461(1-2):411-8. doi: 10.1016/j.ijpharm.2013.12.010. Epub 2013 Dec 17. Int J Pharm. 2014. PMID: 24361267
242 results